Stealth needle
Reference number | |
Coordinator | SAGA SURGICAL AB |
Funding from Vinnova | SEK 998 000 |
Project duration | June 2018 - October 2019 |
Status | Completed |
Purpose and goal
The purpose of this project was to verify our new solution for safer diagnosis of prostate cancer. Vinnova´s grant aimed at taking the solution from TRL3 to TRL 6 including a human pilot pilot study. In the project, we also conducted a market survey.
Expected results and effects
The project has been very successful, and we are one step closer to CE marking and market introduction. During the pilot study, the patients and healthcare professionals experience of the solution was positive. The result of the study exceeded our goal.
Planned approach and implementation
The objectives for this project were realistic and feasible. We did underestimate the amount of time needed, especially the production time and availability of external manufacturers. Cooperation between the project partners worked really well and everyone has contributed. Final result exceeding our expectations. Vinnova has really helped us get through a critical phase.